Jeffrey S. Haug

3.9k total citations · 1 hit paper
30 papers, 2.4k citations indexed

About

Jeffrey S. Haug is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Jeffrey S. Haug has authored 30 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 8 papers in Hematology and 4 papers in Oncology. Recurrent topics in Jeffrey S. Haug's work include Hematopoietic Stem Cell Transplantation (6 papers), Genomics and Chromatin Dynamics (6 papers) and Computational Drug Discovery Methods (3 papers). Jeffrey S. Haug is often cited by papers focused on Hematopoietic Stem Cell Transplantation (6 papers), Genomics and Chromatin Dynamics (6 papers) and Computational Drug Discovery Methods (3 papers). Jeffrey S. Haug collaborates with scholars based in United States, Japan and India. Jeffrey S. Haug's co-authors include Linheng Li, Xi He, Justin C. Grindley, Jason T. Ross, George Melnykovych, Tong Yin, Leanne M. Wiedemann, Jiwang Zhang, Hong Wu and Ryohichi Sugimura and has published in prestigious journals such as Nature, Cell and Genes & Development.

In The Last Decade

Jeffrey S. Haug

30 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention

2006 640 citations Jiwang Zhang, Justin C. Grindley et al. Nature profile →

Peers

Countries citing papers authored by Jeffrey S. Haug

Since Specialization

Citations

This map shows the geographic impact of Jeffrey S. Haug's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey S. Haug with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey S. Haug more than expected).

Fields of papers citing papers by Jeffrey S. Haug

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey S. Haug. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey S. Haug. The network helps show where Jeffrey S. Haug may publish in the future.

Co-authorship network of co-authors of Jeffrey S. Haug

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey S. Haug. A scholar is included among the top collaborators of Jeffrey S. Haug based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey S. Haug. Jeffrey S. Haug is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of stem cells from large cell populations with topological scoring 2020 ·Molecular Omics ·Mihaela E. Sardiu, Andrew Box, Jeffrey S. Haug, Michael P. Washburn	2
2	scRNA-Seq reveals distinct stem cell populations that drive hair cell regeneration after loss of Fgf and Notch signaling 2019 ·eLife ·Mark E. Lush, Daniel C. Diaz, (unknown), Sungmin Baek, (unknown), (unknown), (unknown), Andrés Romero‐Carvajal, Elisabeth M. Busch‐Nentwich, Anoja Perera, Kathryn Hall, Allison Peak, Jeffrey S. Haug, Tatjana Piotrowski	99
3	Therapeutic Targeting of MLL Degradation Pathways in MLL-Rearranged Leukemia 2017 ·Cell ·Kaiwei Liang, Andrew Volk, Jeffrey S. Haug, Stacy A. Marshall, Ashley R. Woodfin, Elizabeth T. Bartom, Joshua M. Gilmore, Laurence Florens, Michael P. Washburn, Kelly D. Sullivan, Joaquı́n M. Espinosa, (unknown), Jiwang Zhang, Edwin R. Smith, John D. Crispino, Ali Shilatifard	89
4	Therapeutic targeting of MLL degradation pathways in MLL‐rearranged leukemia 2017 ·The FASEB Journal ·Kaiwei Liang, Andrew Volk, Jeffrey S. Haug, Stacy A. Marshall, Ashley R. Woodfin, Elizabeth T. Bartom, Joshua M. Gilmore, Laurence Florens, Michael P. Washburn, Kelly D. Sullivan, Joaquı́n M. Espinosa, (unknown), Jiwang Zhang, Edwin R. Smith, John D. Crispino, Ali Shilatifard	2
5	The Dlk1-Gtl2 Locus Preserves LT-HSC Function by Inhibiting the PI3K-mTOR Pathway to Restrict Mitochondrial Metabolism 2015 ·Cell stem cell ·Pengxu Qian, Xi He, Ariel Paulson, Zhenrui Li, Tao Fang, John M. Perry, Fengli Guo, Meng Zhao, (unknown), Aparna Venkatraman, Jeffrey S. Haug, Tari Parmely, Hua Li, Rick T. Dobrowsky, Wen‐Xing Ding, Tomohiro Kono, Anne C. Ferguson‐Smith, Linheng Li	131
6	Mitotic Transcriptional Activation: Clearance of Actively Engaged Pol II via Transcriptional Elongation Control in Mitosis 2015 ·Molecular Cell ·Kaiwei Liang, Ashley R. Woodfin, Brian D. Slaughter, Jay R. Unruh, Andrew Box, Ryan Rickels, Xin Gao, Jeffrey S. Haug, Sue L. Jaspersen, Ali Shilatifard	89
7	Functional Genomic Analysis of the Periodic Transcriptome in the Developing Drosophila Wing 2014 ·Developmental Cell ·Liang Liang, Jeffrey S. Haug, Chris Seidel, Matthew C. Gibson	16
8	The Imprinted Dlk1-Gtl2 Locus Epigenetically Regulates Primitive Hematopoietic Stem Cell Mitochondrial Function and Energy Metabolism Via Repression of PI3K/Akt/mTOR Pathway 2014 ·Blood ·Pengxu Qian, Xi He, Ariel Paulson, Jeffrey S. Haug, Linheng Li	2
9	Maternal imprinting at the H19–Igf2 locus maintains adult haematopoietic stem cell quiescence 2013 ·Nature ·Aparna Venkatraman, Xi He, Joanne L. Thorvaldsen, Ryohichi Sugimura, John M. Perry, Tao Fang, Meng Zhao, (unknown), Rebeca Sánchez‐Domínguez, (unknown), Lai Peng, Jeffrey S. Haug, Ariel Paulson, Hua Li, Xiao-bo Zhong, Thomas L. Clemens, Marisa S. Bartolomei, Linheng Li	220
10	Noncanonical Wnt Signaling Maintains Hematopoietic Stem Cells in the Niche 2012 ·Cell ·Ryohichi Sugimura, Xi He, Aparna Venkatraman, Fumio Arai, Andrew Box, Craig L. Semerad, Jeffrey S. Haug, Lai Peng, Xiao-bo Zhong, Toshio Suda, Linheng Li	213
11	Cooperation between both Wnt/β-catenin and PTEN/PI3K/Akt signaling promotes primitive hematopoietic stem cell self-renewal and expansion 2011 ·Genes & Development ·John M. Perry, Xi He, Ryohichi Sugimura, Justin C. Grindley, Jeffrey S. Haug, Sheng Ding, Linheng Li	140
12	N-Cadherin Expression Level Distinguishes Reserved versus Primed States of Hematopoietic Stem Cells 2008 ·Cell stem cell ·Jeffrey S. Haug, Xi He, Justin C. Grindley, (unknown), Karin Gaudenz, Jason T. Ross, Ariel Paulson, (unknown), Yucai Xie, Ruihong Zhu, Tong Yin, John M. Perry, Mark Hembree, (unknown), Glenn L. Radice, Christopher Seidel, Linheng Li	113
13	PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention breakdown → 2006 ·Nature ·Jiwang Zhang, Justin C. Grindley, Tong Yin, (unknown), Xi He, Jason T. Ross, Jeffrey S. Haug, (unknown), (unknown), Leanne M. Wiedemann, Hong Wu, Linheng Li	640
14	Sterile and disposable fluidic subsystem suitable for clinical high speed fluorescence‐activated cell sorting 2006 ·Cytometry Part B Clinical Cytometry ·(unknown), (unknown), (unknown), (unknown), (unknown), Jiwang Zhang, Karen Staehling-Hampton, Linheng Li, Jeffrey S. Haug	10
15	Evaluation of developmental phenotypes produced by morpholino antisense targeting of a sea urchin Runx gene 2004 ·BMC Biology ·James A. Coffman, (unknown), Jeffrey S. Haug, John J. McCarthy, A Robertson	29
16	Transduction and selection of human T cells with novel CD34/thymidine kinase chimeric suicide genes for the treatment of graft-versus-host disease 2003 ·Molecular Therapy ·Michael P. Rettig, Julie Ritchey, Todd E. Meyerrose, Jeffrey S. Haug, John F. DiPersio	26
17	Mechanism of Farnesol Cytotoxicity: Further Evidence for the Role of PKC-Dependent Signal Transduction in Farnesol-Induced Apoptotic Cell Death 1995 ·Biochemical and Biophysical Research Communications ·Paul Voziyan, Jeffrey S. Haug, George Melnykovych	65
18	Differences in sensitivity to farnesol toxicity between neoplastically- and non-neoplastically-derived cells in culture 1994 ·Cancer Letters ·Istvan Adany, Eugenia M. Yazlovitskaya, Jeffrey S. Haug, Paul Voziyan, George Melnykovych	50
19	Directed cell killing (apoptosis) in human lymphoblastoid cells incubated in the presence of farnesol: Effect of phosphatidylcholine 1994 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Jeffrey S. Haug, (unknown), Eugenia M. Yazlovitskaya, Paul Voziyan, George Melnykovych	74
20	Growth inhibition of leukemia cell line CEM-C1 by farnesol: Effects of phosphatidylcholine and diacylglycerol 1992 ·Biochemical and Biophysical Research Communications ·George Melnykovych, Jeffrey S. Haug, (unknown)	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact